Global University Venturing

Rogue has achieved a first close for its fourth fund, although it is as-yet unclear whether Oregon State University is again an investor.

University of Oxford and OSI have both returned for a $95.4m series C round that also included GV and, through the conversion of a note, Eli Lilly.

Washington University in St Louis joined a consortium of investors that provided $130m in series B financing to the commercial space station developer.

Amadeus Capital Partners has bought a stake in the University of Oxford spinout through a secondary transaction, valuing it at around $2.4bn.

The Johns Hopkins University spinout’s latest funding will go toward further developing its lead candidate, VTA-110, for muscular dystrophy treatments.

The Industrifonden-led tranche has helped the Stockholm spinout lift the round to $13.3m, which will be used to conduct a proof-of-concept run.

The Kyoto University spinout backed by the institution’s i-Cap fund has secured $25.5m in funding from returning investors.

Caltech spinout Talis Biomedical has raised more than $220m in an initial public offering on the Nasdaq Global Market.

TU Darmstadt spinout Akasol had floated on the Frankfurt Stock Exchange in 2018 and has now agreed to an acquisition by BorgWarner.

Ensoma has emerged with $70m in series A financing to advance research from Fred Hutchinson and University of Washington.

NexImmune priced shares at $17 to raise $110m in an upsized offering, enabling Amgen and Pfizer to exit the Johns Hopkins University spinout.